missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Fibrillin 1 Monoclonal Antibody (11C1.3), Invitrogen™
Mouse Monoclonal Antibody
Marque: Invitrogen MA512770
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
MA5-12770 targets Fibrillin-1 in ICC/IF, IHC (F), IM, and WB applications and shows reactivity with Bovine and Human samples. The MA5-12770 immunogen is microfibrils from zonular apparatus of bovine eye.
Fibrillin 1 is an extracellular acidic protein with a high cysteine content and an extended thread-like shape with mosaic composition of different types of extracellular modules. Most of the fibrillin molecule is contributed by 47 epidermal growth factor-like (EGF-like) repeats; 43 of them have a consensus sequence for calcium binding (cb). Other modules including 8-cysteine motifs (seven), hybrid motifs (two), and unique domains (three) are interspersed throughout the molecule[3-7]. Fibrillin 1 contains a proline-rich region close to the N-terminus that is replaced by a glycine-rich region in Fibrillin 2. The fibrillins are found throughout the connective tissue as integral components of extended fibrils.
Spécification
| Fibrillin 1 | |
| Monoclonal | |
| 0.2 mg/mL | |
| PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 | |
| P35555, P98133 | |
| FBN1 | |
| Microfibrils from zonular apparatus of bovine eye | |
| 500 μL | |
| Primary | |
| Bovine, Human | |
| Antibody | |
| IgG1 κ |
| Immunocytochemistry, Immunohistochemistry (Frozen), Immunomicroscopy, Western Blot | |
| 11C1.3 | |
| Unconjugated | |
| FBN1 | |
| ACMICD; AI536462; Asprosin; B430209H23; ECTOL1; FBN; Fbn1; Fbn-1; Fib-1; fibrillin 1; fibrillin 15; fibrillin-1; GPHYSD2; MASS; MFLS; MFS1; MP340; OCTD; putative; SGS; SSKS; tight skin; Tsk; WMS; WMS2 | |
| Mouse | |
| Protein G | |
| RUO | |
| 2200, 281154 | |
| 4° C | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu